CME Group Inc
NASDAQ:CME
Earnings Call Analysis
Q3-2023 Analysis
CME Group Inc
As a value investor, consistent performance can be an attractive feature in a potential investment. The mentioned company has impressively achieved its ninth consecutive quarter of double-digit revenue growth, signaling robust financial health and potentially reflective of effective management, market dominance, or sector growth.
Management's discussion of Federal Reserve policy suggests strategic thinking. With the Fed ceasing treasury acquisitions, there will be a shift in demand that other market participants will need to fulfill, and most of these participants will need to hedge their positions. This dynamic could affect the company positively by increasing hedging activity through their services.
Investors should take note of the company's expense control prowess, particularly in an inflationary environment. A mere 3.6% increase in core expenses has been projected for the year, which the company attributes to their strict expense discipline. The ability to control costs facilitates investment in growth initiatives, potentially boosting the bottom line—this indicates prudent financial management and operational efficiency.
The company's treasury operations observed substantial cash balances averaging $91 billion with a 36 basis point yield and non-cash balances averaging $137 billion at 7 basis points. However, there has been a strategic shift with cash balances decreasing and non-cash collateral increasing, coupled with a planned hike in the fee charged on non-cash collateral from 7 to 10 basis points starting January. Such a move could enhance revenue from treasury operations.
Regulatory challenges pose risks but can also present opportunities. The company notes a lack of consensus among regulators regarding Basel III proposals, signifying potential stability or volatility based on future regulatory developments, which could influence their market position and operational approach. This uncertainty can affect market efficiency, and investors should be aware of its implications.
The company’s SOFR complex has already seen a 14% increase year-to-date compared to the best year in their Eurodollar history, and this is without the calculations of the fourth quarter. This indicates solid adoption and integration into the market ecosystem, which is a positive sign for investors looking for innovative growth in financial product offerings.
An expanding global footprint is a strong indicator of market leadership. The company's Q3 international volume was up 7% from the previous year, led by higher RPC products and staggering growth in specific segments like agriculture (up 32%) and energy (up 30%). The non-U.S. options volume also increased significantly by 31%. Such diversified growth, along with strategic boots-on-the-ground investments, positions the company favorably for continued international expansion and dominance heading into the new year.
You don't have any saved screeners yet
Greetings, and welcome to the CME Group Third Quarter 2023 Earnings Call. [Operator Instructions]
I would now like to turn the conference over to Adam Minick. Please go ahead.
Good morning. I hope you're all doing well today. We will be discussing CME Group's third quarter 2023 financial results. I'll start with the safe harbor language, then I'll turn it over to Terry.
Statements made on this call and in the other reference documents on our website that are not historical facts are forward-looking statements. These statements are not guarantees of future performance. They involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any statement. Detailed information about factors that may affect our performance can be found in the filings with the SEC, which are on our website.
Lastly, on the final page of the earnings release, you will see a reconciliation between GAAP and non-GAAP measures.
With that, I'll turn the call over to Terry.
Thanks, Adam, and thank you all for joining us this morning. We released our executive commentary earlier today, which provides details on the third quarter of 2023. I'll make a few brief comments on the quarter and current outlook, and Lynne will summarize our financial results. In addition to Lynne, we have other members of our management team present to answer questions after the prepared remarks.
Turning to the most recent quarter. Average daily volume of 22.3 million contracts was less than 1% off the record Q3 high set in Q3 2022, while our revenue grew 9% to $1.34 billion, which is the highest Q3 revenue in CME Group's history.
As we've mentioned throughout this year, we are operating in an environment that unquestionably requires risk management. With so much uncertainty in the world we live in, we're continuing to work closely with our clients to help them navigate uncertainty and manage their risks.
This is particularly true in the interest rate markets today. We see divergent market views around inflation, unemployment, monetary policy and ongoing geopolitical tensions, all impacting future interest rate expectations. Regardless of whether rates rise, fall or hold steady, the shape of the yield curve and interest rate views continue to shift, and our customers need to manage that risk.
As a result, we have continued to see growth on top of the record year in 2022 for our interest rate business. This was our highest Q3 for our interest rates complex, up 6% from the same quarter last year. We saw particular strength in the treasury complex, which was up 16% in the quarter and is off to a strong start in Q4 as well.
Completing the successful migration of Eurodollars to SOFR, we continue to list other products to complement our interest rate complex today. Our European short-term rate, or ESTR contracts, traded a record 10,000 contracts per day in September.
Our newly listed treasury bill futures launched on October 2, and we have traded over 15,000 contracts in the first 3 weeks. This is one of the most successful launches of a [ rates ] product ever. Our broad product offering and focus on capital efficiencies, such as the enhanced cost-margining agreement with DTCC going live in January of 2024, continue to enhance the value proposition for our customers using our products to manage their interest rate exposure.
On the commodity side, third quarter 2023 volume was up 15% in total and included the highest-ever Q3 volume for our agricultural products. Our energy complex also performed well, with volume increasing 16% from last year. We believe the current environment for this asset class will continue to bring new clients as well as existing ones to manage their exposure in our global benchmark.
We believe the strong macro environment, combined with our diverse set of asset classes and strategic execution across our growth initiatives, positions us well for continued growth in 2023 and beyond.
With that, I'll turn it over to Lynne to cover the third quarter financial results.
Thanks, Terry. During the third quarter, CME generated $1.34 billion in revenue, up 9% compared with a strong third quarter of last year. Clearing and transaction fees and market data revenue each grew 9% versus Q3 '22. Expenses continue to be very carefully managed, and on an adjusted basis, were $448 million for the quarter and $369 million excluding license fees, both lower than the second quarter this year. This quarter, our investment in the cloud migration was approximately $13 million.
Our adjusted operating margin for the quarter expanded to 66.5%, up approximately 240 basis points compared with the same period last year. CME Group had an adjusted effective tax rate of 22.8%, which resulted in net income of $818 million and adjusted diluted earnings per share of $2.25, each up 14% from the third quarter last year. Of the $110 million increase in revenues versus last year, we were able to drive 90% to the bottom line with adjusted net income up $99 million.
As a result of the strong expense discipline throughout the firm, we are lowering our core expense guidance, excluding license fees, to $1.475 billion, a $15 million decrease from our original guidance of $1.49 billion. We are maintaining our guidance of $60 million for our cloud migration expense for a total expense guidance of $1.535 billion excluding license fees.
We continue to manage our capital expenditures effectively with an eye towards our move to the cloud. As a result, we are lowering our CapEx guidance [ to ] $85 million. For the quarter, our capital expenditures were approximately $18 million. CME paid out $2.8 billion of dividends so far this year, and cash at the end of the quarter was approximately $2.5 billion.
Our strong financial results this quarter continued to build on the strength achieved in the first half of the year. This quarter, we delivered our ninth consecutive quarter of double-digit adjusted earnings growth. Our global benchmarks, data and strong focus on innovation and execution continue to address the needs of our clients and deliver results for our shareholders. Please refer to the last page of our executive commentary for additional financial highlights and details.
We'd now like to open up the call for your questions. [Operator Instructions] Thank you.
[Operator Instructions] Our first question is from the line of Dan Fannon with Jefferies.
Terry, a question for you on M&A. You've been vocal about your financial capacity to do additional transactions. I was hoping you could talk about kind of the scope and what you're looking at.
And also, in the context of the current environment, why now? Have valuations come in? Are your competitors distracted with other deals or other tasks? So curious about the current backdrop of what you're looking -- what you're thinking about and really the scope and what that may look like.
Yes. Thanks, Dan. I think that's the reason why people sometimes need to read the whole story and not just the headline. Because if you read the whole story, I haven't said anything different than what I've said for several years, is I was only stating facts to the point where our capacity is much greater than everybody else's because we've stayed very disciplined and very focused as it relates to our M&A transactions that we've done. I was only referring to our EBITDA being lower than 1x compared to some of our competitors who were at multiples of that.
When asked the question, if deals are to be offered, I made the reference to the comment that where else would you want to shop something but the CME? It doesn't mean that CME is interested, but that's all I was referencing. So my appetite for this hasn't changed a bit. We have not looked at anything that I -- to a point where I said, "Okay, we want to do a deal." I was only referencing what I've been saying for a number of years.
And unfortunately, the headlines say what they're going to say. So there's not much more I can say about it than that, Dan. But again, nothing has changed from our discipline. And again, if I -- we see something -- and I said this publicly and I believe this. If we see something that benefits our users and benefits our shareholders, we will take a very strong look at it to build and grow this great company. That's all I was saying.
Our next question is from the line of Patrick Moley with Piper Sandler.
So Terry, I was hoping you can maybe just give us your updated thoughts on the outlook for volumes heading into year end, just given some of the evolving yield curve dynamics we've seen in this kind of heightened geopolitical uncertainty.
And then coming into this year, you talked a lot about how great the setup was for CME's business. So maybe if you could just talk about how that maybe compares now to -- or how it's played out relative to your expectations, and how it maybe compares to the setup we're now looking at heading into 2024.
Yes. I think the good -- and thank you, Patrick. I appreciate it. I think it's really hard to predict the future, and I try to be careful. But the setups that we saw in 2022, which you're referring to, and 2023, were something so glaring that you had to call it out because of the geopolitical events, what was going on with inflation where people were calling it transitory versus you sprinkle $3 trillion into the American public's hands, you know that it's not going to be transitory.
So I was only sprinkling out the favorable events that we were seeing fundamentally that I thought was good for every single one of our asset classes. And it was actually very good for us. As you know, with a record year in 2022 and an amazing quarter this quarter in 2023, and as Lynne said, our ninth consecutive quarter of double-digit revenue growth.
So those are all very impressive numbers. We will -- I don't think the setup has changed, Patrick, when you look at what's going on right now, that's going to be much different for 2024. I think we're going to see a little bit of the same, but who knows? It's hard to predict what the volumes would be associated with that. But there is a massive amount of uncertainty out there.
When we made comments like we did in '22 and '23, we also didn't have the unfortunate situation we're seeing in the Middle East today. So there's another added component going on to that. And then we also have other situations, as I said earlier as it relates to our energy complex, where people are looking for more production coming out of the U.S., and Derek can touch more about that throughout the Q&A. But again, I think that bodes well for CME's products. But I'll -- beyond that, I'll be careful what I say.
Our next question is from the line of Alex Kramm with UBS.
Just quickly on the regulatory side. Seems like the SEC is getting closer to mandating treasury clearing on the cash side. Obviously, you have your arrangement with DTCC now in place starting in January. So a good position there, I guess.
But like more broadly, just wondering how you think treasury clearing would change the marketplace, both on the cash side and maybe even on the futures side, customer behavior, new customers. Anything -- I assume you have some thoughts on it. So anything would be helpful, how market structure may change if that happens.
Yes. No, thank you very much. And it's a great question because it's a great unknown, too, what's going on out there. And what is being proposed and what may happen is still being hammered out.
I'm going to ask Suzanne Sprague, who is the president of my clearinghouse, to give you some comments on the reg side of it. She's working closely with her team as they're watching this. And then I'm going to turn it over to Tim McCourt from an opportunity perspective, what he's seeing as it relates to the complex if, in fact, some of these things happen or even if they don't.
So maybe we'll give you a little 2-part answer here, Alex, if you don't mind.
Yes. Thanks, Terry. We do think generally the benefits of central clearings will bring the marketplace into a strong position for things like our cross-margining program with the Fixed Income Clearing Corporation. So you are correct to put those dots together, that it will potentially enable higher participation in that program.
We do today have the program that's eligible for common clearing members. And so the enhancements will benefit those common clearing members within the program. And therefore, increased activity through clearing of treasuries generally should translate to more eligible activity that could benefit from cross-margining between CME and the Fixed Income Corporation.
So we generally believe the benefits of central clearing, plus those enhancements to the cross-margin program, will position us and the industry well for taking advantage of more capital efficiencies in this space.
I'll turn it over to Tim McCourt to add anything else as well.
Sure. And thanks, Alex, for the question. I think when we think about the opportunity, why we remain excited and very optimistic that the cross-margin agreement is finally coming online in January of next year, is because this is something that we've seen before in our other markets. When you unlock the capital efficiencies of related products, it significantly increases the risk management capabilities of the marketplace and can lead to increased trading velocity in the product.
While, as Terry said, it's hard to predict the future, if we look at some of the other areas we've unlocked capital historically, portfolio margining of futures versus swaps is probably a pretty good analog to look at, and that's been in place since 2012. Since that's been put in place, the average daily savings have grown from $1 billion in 2013 to a little over $7.5 billion today in 2023. And at that same time, our rates volume grew 109% and open interest doubled in the complex. And our cash market participation went from about 54% over 100%.
So certainly, unlocking capital is beneficial to the volume and the velocity of the complex. And we're optimistic about what we can do once this comes online early next year.
Hopefully that gives you a little color to your question, Alex.
Our next question is from the line of Owen Lau with Oppenheimer.
So it's somehow related to the last question, but I think you talked about government budget deficit in the past leading to more treasury issuance, which could increase like more hedging activities. Could you please unpack a little bit more on that relationship? Are you saying, when we see more treasury issuance, that should like kind of induce higher trading activity? I think any more color would be helpful.
Yes, Owen, it's Terry Duffy here. And one of the things that we have said historically, and if you recall some of the comments that our former colleague, Mr. Sean Tully, made over the years that, when the Fed no longer is acquiring some of these treasuries, that the demand for them will have to go somewhere else.
The Fed does not hedge their treasury portfolio, as you know. The other people that acquire the issuances coming out from the government need to hedge those. So it's hard to predict what the issuance is going to be. But again, those -- the parties that will be taking the issuance, if it's not the Fed, are traditionally people that hedge those in our marketplace. So that should benefit CME.
So Tim, maybe you want to add anything more to that?
Yes. Sure. Thanks, Owen. When we look at the net issuance of treasury securities, they increased significantly in Q3 compared to Q2, up almost 80%. And that's not surprising. If you remember, this is really looking at the replenishment of the treasury general account, which reached a record low of just under $50 billion prior to the debt ceiling. And at the end of September, that balance stood about $672 billion.
Now it's important, to Terry's point, to look at where that debt is being issued. And comments made previously, a lot of the issuance is going into T-bills on the short end of the curve. That's what we saw in Q1, Q2, and that pattern has not changed here in Q3.
So with respect to how that can impact our complex in treasuries, one would assume that, if we look back over historical distributions of how the treasury has looked to issue debt, there's only so much that can go into the front end of the curve. It was perhaps a little bit below the historical norms the last several years where the treasury has taken advantage of the lower rates further out the curve.
So one can reasonably conclude, going forward, they would look further out the curve to be more in line with their traditional or historical allocation, where that's where our complex at CME has all the historical products. As Terry noted, the growing treasury complex from both a volume and an OI perspective, we would expect that issuance further out the curve in the coupons and bonds to increase the velocity as the marketplace looks to digest that issuance, hedge the related trading activity of it.
And with the introduction of our T-bills earlier this year that's off to a great start, we now also have tradable products across the entirety of the curve, and even better suited for that risk management needs of the marketplace as they find ways to absorb this increasing debt being issued to the market.
Our next question is from the line of Brian Bedell with Deutsche Bank.
Great. I have a couple of questions. I'll get back in the queue for the second one. The first question I have is on just on the -- I guess there's some talk of more regulatory -- or potentially more regulatory scrutiny around basis trading within futures and treasuries.
And just wanted to get your perspective on how you view any potential scrutiny there, or the merits of that trade. And I don't know if you're able to potentially size the impact on volumes. I know it can be -- can change quite dramatically over cycles, so maybe it's tough to do. But just wanted to get a sense.
Yes. And Brian, it's Terry. I'm going to turn it over to Tim. But sometimes, there's problems looking for solutions, as they say, or solutions looking for problems. And this is government at its finest trying to introduce new legislation where there is no problem. With the basis trade, it's something that will continue to move as well as it should, and the basis trade is actually what keeps the markets in line.
So we feel very strongly that this is going to continue to keep the market efficient. And the more you explain that to regulators to show them what kind of potential chaos you could introduce if, in fact, you have additional regulation that takes people out of that trade, which widens the basis, they may not like that outcome.
So let me turn it over to Tim to give you a little bit more color. But I would be cautious to draw the conclusion that any kind of pending regulation is coming down the pike in any time soon. Tim?
That's correct, Terry. I think the one thing I would add is that the existence of basis between cash and futures market is not an isolated phenom to the treasury market. We see this in almost all of our asset classes here at CME.
And the fact that you can independently trade the basis as a stand-alone risk parameter is an important key element to keep these markets aligned and arbitrage-free. It's something that we've seen as vital to the marketplace for this purpose, and it's something that we also see remaining in this market. It's not surprising, with rates traversing the range that they have, that you're going to see different behavior of the basis than we have in previous decades when we've seen similar activity. And it's something that we engage with the market.
And the one thing I would note is that it's also important that CME also has the ability to trade cash treasuries on BrokerTec, and the futures, which is also both leading price discovery mechanism. So we are the natural home for this trade to take place, and we continue to work with the marketplace. Now we can increase the efficiency of this trade going forward and work even more closely with market participants to make sure we unlock the value that still exists between bringing the BrokerTec and our futures business together at CME.
Our next question is from the line of Kyle Voigt with KBW.
Maybe just a question on expenses. Good to see the lower expense guide today. But just given the slightly higher kind of inflationary environment and still relatively tight labor market, just wondering if you could remind us how you think about steady-state organic expense growth on a medium-term basis for this business within the current macro backdrop. And then second part of that question, as we're approaching the end of the year here, can you also just remind us how the Google-related expenses are expected to unfold into 2024 versus 2023 level? So I think there was spend for the first 4 years, but just maybe give us an update on where you stand with that spend today and when that starts to wind down.
Thank you, Kyle. Lynne, do you want to address both of those issues?
Yes, sure. So overall expense guidance, if you look at our estimate for this year, that's up about 3.6% on our core expenses despite the inflationary environment. So I think what you've seen from us over the years is really tight expense discipline and expense control. We're always looking for ways to minimize the -- run the business expense to become more efficient so that we can have more of our expense base going through -- to growth initiatives and helping to grow the bottom line.
So I think we have a strong track record there. If you look back in history, it averaged between that 3% to 3.5% over the last several years. Certainly, as we look forward, we'll continue that same type of discipline, and we'll look to provide guidance as we get closer to year-end.
On the Google front, we did guide that we would have 4 years of incremental cash costs in the range of $30 million per year on average. So our expense guidance for this year, this is our second year, is $60 million in expense, offset by $20 million in CapEx savings, to get to a net $40 million. We had $30 million in net expenses last year. So we have 2 more years where we think there will be an incremental expense associated with the Google migration before we see -- start to see breakeven and ultimately cash flow positive.
Our next question is from the line of Benjamin Budish with Barclays.
Terry, in your comments, you talked about the kind of uncertain rate environment and ongoing need for participants to manage risk. Earlier in the year, you talked about the opportunity with regional banks. But maybe just at a high level, how do you see that opportunity more broadly? Is it kind of new participants that haven't been on CME's platform before? Is it more involved hedging from existing participants? How do you see kind of like the medium-term TAM coming from that environmental need that you see?
Yes. I think it's hard to -- for us to describe if it's the regional banks or the bigger banks hedging. I mean, Suzanne can help me with more color on that as who the exact participants are because they come in to -- only the bigger banks anyway, even the smaller ones do. So we're not quite sure which one is laying out the risk.
Yes, I would agree with that. It's generally appealing, I would say, for both of those groups of folks to engage with us on an ongoing basis, especially now with the uncertainty in the rate environment, to think through the offerings that we have from a capital efficiency standpoint as well as a general risk management standpoint for ensuring that there aren't additional micro or macro events that will, I guess, circulate in the industry.
SVB is one example of a lot of engagement that we've had, leading up to and afterwards, with clients about the way that we provide services and clearing solutions to allow people to manage risk as well as the product side. So I think it is hard to specifically identify what portion of those participants might be new and existing, but we have been engaging pretty broadly in the marketplace around those events to make sure that the products and services, as well as the way that the clearinghouse offers risk management services, are accounted for and available for market participants more broadly to get ahead of any other events that might be circulating in the industry.
And just to add to that, Ben. Thank you, Suzanne, that's a great answer. But just to add to that, Ben, the duration risk that we saw take down SVB has not gone away. As we talked about earlier in our comments, the issuance that is coming out from the government seems quite large in order to run and pay our bills in this government, and the demand has been a little bit lighter. So in return, whether we like it or not, rates are continuing to be very stubborn regardless of what the Fed does or does not do.
So I think that we're not suggesting there will be more duration risk. But what I am suggesting is that people are going to have to manage that. And so whether it's the biggest of banks or the mid-tier banks, the risk management associated with duration, not only is it not going away, in my opinion, it's increasing because of the fundamentals of the overall treasury market in general. So from our standpoint, we think that will lend to more people mitigating and managing risk through our treasury complex from all different sizes of the banking world.
Our next question is from the line of Chris Allen with Citi.
I was wondering if you could provide color on the average collateral balances for cash, noncash in the quarter. And then with respect to the yields and then where they stand at present.
Lynne?
Sure, Chris. Happy to. So if you look at quarter 3, the average cash balances were $91 billion. The yield on that averaged 36 basis points. For noncash, we averaged $137 billion yielding 7 basis points.
If you look at October to date, the cash balance has trended down. We're seeing average cash balances of $71 billion and a shift into the noncash collateral, which is up to $152 billion. I would point out that on the noncash collateral side, we did announce a fee change that takes effect in January where the charge on the noncash collateral will be increasing from a blended 7 basis points up to 10 basis points.
Just to give that a little sizing. If you apply that change to this quarter's average volume, that would have added $10 million to the revenue associated with the noncash collateral, which rolls through other revenue.
Our next question is from the line of Ken Worthington with JPMorgan.
As we go into year-end, maybe could you talk about how you're thinking about price increases in data and trading for 2024, particularly in the context of the fairly sizable changes you made in 2023?
Okay. Ken, thank you. I'm going to ask Lynne to start. And then Julie Winkler, who heads up our data organization as our Chief Commercial Officer, will participate as well. So Lynne?
Yes. So as you know, on the clearing and transaction fee side, we typically announce any changes there later in the year. It's typically around the late November time frame. Our approach is the same as it's always been. It will be a bottoms-up approach looking at all the different markets, looking at health of the market, the value we've created, the health of our customers and the total cost of trade, including not only clearing and transaction fees, market data fees, but also the cost of collateral and making sure that we don't do anything from a fee perspective that would impact volume or liquidity given our high incremental margin.
So as I mentioned, we have increased that noncash collateral fee effective in January that runs through other revenue. And Julie has announced some market data fee changes, which take effect in January as well. Julie, do you want to walk through those?
Yes. I mean, Q3 was another record quarter of $167 million in data revenue, so up another 9% year-on-year. And I think the strong growth also is something that, as we look into 2024, yes, there will be some fee adjustments, but we also are looking for continued new product development, active sales efforts, continued education and also our enforcement efforts. So it should be noted, even in this quarter, we saw about $4.9 million in nonrecurring revenue that was reflective of both those prior period activities from subscriber adjustments as well as that audit revenue that we sometimes talk about.
And so similarly with the transaction-based business that Lynne just referenced, we're continually evaluating the pricing of these data offerings. We have a very large and diverse set of offerings. So it's difficult to really specify a specific increase to forecast for 2024. Many of our data products, however, will see price increases next year ranging from 3% to 5%, kind of reflecting that price-to-value approach. However, again, this is dependent on both subscribers as well as that nonrecurring revenue that occurs in most quarters. So hope that's helpful.
Our next question is from the line of Alex Blostein with Goldman Sachs.
I was hoping you can opine on some of the potential new competitive dynamics and developments in interest rate futures markets with FMX Futures potentially entering the space and partnering with LCH.
Now we've seen this movie before, right, multiple times, and all these kind of attempts have been unsuccessful. So wonder whether or not this might feel different given LCH position as the largest pool of clearing in the swaps market. Maybe just a reminder of sort of the benefits that customers get by keeping everything in futures and the savings across the portfolio they can get versus the alternative of trying to kind of cross margin between futures and swaps.
Thanks, Alex. And I'm going to ask Tim and maybe some of my other colleagues around the table to comment as well.
But when we're looking at the FMX proposal, it's -- we haven't seen all their details. And I think -- so it's really hard to comment on exactly what the competitive offering is going to be, other than what you just referenced. I understand what you said.
I think with the announcement of DTCC and the offsets that we are going to be able to supply to the users, is going to be an extremely powerful benefit to the participants of the marketplace. And you also have to remember that FMX is coming from a position of 0 futures trading today.
And where we are sitting on, as Tim has referenced, record open interest in treasury complex, listing new products and listing the benefits thereof. We are ready and able to compete with anybody. And competition is something that has made CME what it is today.
But the benefits that we continue to work on. You've heard me say this for years, that we are going to continue to look for capital efficiencies in each and every one of our asset classes. We are delivering on every one of those asset classes to deliver capital efficiencies. That does not go lost on the participants in a capital-intensive world. So when you're talking about new offerings with LSE and what they could potentially offer versus what we have, we think we have a massive compelling offering for our clients that saves them additional funds.
So I like our position, and I think we are in a position of strength. Again, I think a lot of people, Alex, as you know very well, when the LIBOR was going away and everybody was going to convert from Eurodollars, us, to SOFR, that people thought it was a jump ball. And we felt we were in a very strong position to transition 100% of that business into CME SOFR products, which we did, because of efficiencies to everything we have to offer. And those go from the back office to my sales team right across the entire organization that creates those benefits.
So I like our position. Again, I think you said it at the beginning of your question. We've seen this movie before. I don't want to quote you wrong, but I think that's what you said. And we will continue to take every party that wants to compete with us very seriously. But at the same breath, we think we have a very strong, powerful, compelling offering for our clients.
Tim, do you want to add to that?
Sure. Thanks, Terry, and thanks, Alex. I think just to add a little more color on that picture, is when we look at the gravity of the complex at CME, Terry's point, this is unmatched. And the one thing I want to further remind the marketplace about is you can unlock a tremendous amount of capital savings and efficiencies at CME today, and the marketplace is doing it.
In addition to the $7.5 billion-plus margin savings from our portfolio -- margining portfolio, let's look at some of the numbers with respect to the open interest, with record average daily open interest in our treasury complex of just under 19 million contracts for the third quarter, a record average daily open interest in our SOFR complex of about 11 million contracts, and with our record large open interest holder population of 3,175 participants.
That is an enormous amount of gravity that, although LCH may be the leader with respect to their interest rate swap clearing offering, I like the gravity and the size of the complex that's going to be unmatched about the capital efficiency the can tap into with CME, the sheer function of our position on the future side, which we expect to only be more and more important to the marketplace as we head into 2024.
Hopefully that gives you a little color on how we're thinking about it, Alex. But again, we take everything seriously. And -- but I think, again, our offering, as Tim has said and I said, is very compelling.
Our next question is from the line of Michael Cyprys with Morgan Stanley.
Two-part question. Just following up on the capital efficiencies beyond the cross margining with DTCC. Just curious what other steps you might be able to take as you look out the next 3 years to further enhance that.
And then the other part of the question is just around the regulators proposing new capital rules for banks that can make some bespoke off-exchange derivatives just more capital-intensive. Just curious of your take on that, where you see the biggest opportunity to bring derivatives from OTC to the exchange-traded marketplace.
Michael, both really good questions. The latter one is we've dealt with in 2017. I'm assuming you're referring to the Basel III, what's being proposed on the second part of your question.
Yes.
Okay. So on the first part, on the capital efficiencies, I'm going to turn it over again to Suzanne Sprague, and she can touch on both. But I'll give you my thought process on the Basel III as well.
Yes. Thanks, Terry. So we do look forward to extending the enhanced cross-margin program to the client level. We have had quite a bit of conversations with ourselves and the Fixed Income Clearing Corporation, as well as clients, on the importance of continuing to broaden that program.
So we don't have any timelines to commit to at this point in time, but it is a focus of ours jointly to be able to expand those enhancements to the end client level, which I think will help even more with things we've already covered on the treasury mandate, and needing more capital efficiencies to address things like increased capital costs under the Basel proposal.
I think Terry will hit it at a high level, the Basel proposal.
Yes, let me just comment on the practicality, Michael, and I know that you've been there for a little while now at your firm and understand how this works. There is 0 consensus amongst the regulators as it relates to some of these proposals in Basel III. Actually, there's really opposing views to that, which makes it very difficult to move something forward, where you have, internally at a regulator, not the same people supporting the proposal.
The markets need to remain efficient. And I guess, again, another solution looking for a problem with Basel III, we have never had an issue under the margin that we're holding that needs to have a capital hit associated with it. We only think that would add to the lack of liquidity to the overall marketplace and make markets less efficient than they are today. And that's not healthy, especially as we laid out the fundamental places that we are in the world today and with the issuance coming forward.
We need to manage this. There's risk in everything we do in this life, including the treasury issuance and who's using it or not. We think we have a very good platform, and we think that the rules that are in place right now makes sense for the users. And if you want to just continue to add capital charges to everything we do, I guess we can constrict it to 0. And we won't have any more risk in the system, but we won't have any economies around the world either.
So I do think it gets to a certain point. Again, like I said earlier, this was proposed in 2017, and it was not agreed upon then. So we'll see where this goes. We are meeting with people in Washington now. My Washington folks are trying to explain the detriment that such a proposal could bring to the overall marketplace.
Our next question is from the line of Craig Siegenthaler with Bank of America.
So in the quarter, there was another instance of vertical integration between an exchange -- or actually secondly, a DCM and an FCM. So now we have Coinbase, MIAX with vertically integrated business models.
So first, I want to get your perspective on what this means for the ecosystem. And then -- and also, CME already registered its FCM last year, I think partly in reaction to FTX's move. So what are your updated objectives for that business now?
So Craig, again, I've been also talking a lot about market structure and how market structures always have a shelf life, and we don't know what the next one is going to look like, but we all need to be prepared for it. And that's what CME will always do. We'll be prepared for anything that comes our way. That's one of the reasons we filed for the FCM application, not just because of FTX. But not to say you're wrong because that was part of the reasons why, but it was, again, around market structure.
I think with these vertically integrated models that is being proposed, such as MIAX, and I think Coinbase is the other one you referenced. The conflict of interest question for the clients is huge. And it would be big for us, too, if we decided to go ahead and deploy an FCM. So we would have to be very careful about that ourselves.
But the same breath, I think that if they're going to go down this integrated model, they need to write rules associated with it. This was my entire complaint around FTX, that they were trying to make existing rules fit for their business proposal. So if in fact we're going to have integrated models of what MIAX is proposing today and going into business in the United States, you need to write rules with them. Because the Commodity Exchange Act clearly states, in the year 2000, that those rules were written with intermediaries in mind, not on a direct model. So not saying you couldn't have intermediaries in the direct model, but the rules are not clear on that.
So I think there's a long way to go. I think one of the reasons they're not getting much attention today on that is because of their size, which I think is wrong to look at it that way. It shouldn't matter, their size. Who's to say they can't get bigger tomorrow? Who's to say we can't do something different tomorrow as well.
So I think there needs to always be rules, and the rules of the road need to be applied so people understand that we do not need situations like '08 and other ones that we could all describe because of people trying to advance businesses that they think is in their best interest without having the public's interest at heart.
So again, we've always been a neutral facilitator of risk management. We will continue to do so. We like the intermediary model. And again, but we don't know what the future is going to hold. But I do -- I am very concerned about some of these existing platforms. And the government needs to look at them and write rules for them if, in fact, they're going to allow them to stay in business.
Our next question is from the line of Andrew Bond, Rosenblatt Securities.
One for Derek on the energy business. So energy markets, particularly natural gas markets, have experienced some structural shifts benefiting North American markets following the Russian invasion of Ukraine. And more recently, with the geopolitical events in the Middle East, are you seeing more of a continuation of these dynamics? And can you talk about the potential longer-term impact of the geopolitical events of late on your markets?
Andrew, thank you. We appreciate it. And Derek?
Yes. Thanks, Andrew. Yes, I think this is kind of proof positive of what we've been talking about for the last couple of years, that structurally, the U.S. is in an incredibly strong position, given the position we have both in crude oil as well as natural gas. As you know, we're currently exporting record amounts of oil from the U.S. at 4.6 million barrels a day. We're also exporting record levels of natural gas, while based on Henry Hub pricing record levels from our U.S. capacity point of view.
So as we've talked about, that structurally positions CME's WTI franchise as kind of the leader in that space and certainly positions WTI as a global benchmark as the U.S. continues to export the marginal barrel outside the U.S. with challenges everywhere else.
Natural gas, as you pointed out, has been a really, really strong point for the energy franchise overall. When you look at what's going on from an uncertainty point of view, options continue to be a significant proportion of our customers' client behavior.
So we like our position in both natural gas and crude oil. When you look at the volume and growth of the -- both futures and options, strong in Q3. More importantly, we continue to see that strength in October with our energy options up 81%, overall energy up 26% in October. So really strong year this year, continuing really strong year into Q4. And the position that we have as the swing producer, both in natural gas and crude oil, I think, positions us well long term in what we think is a potentially multigenerational energy shift.
Our next question is a follow-up from Alex Kramm with UBS.
Just a quick one on the interest rate business again. You guys, Terry, mentioned the LIBOR-SOFR transition. Obviously, that's now behind us and successful. But just maybe looking back on that. I think early on, there were some concerns that SOFR would not be the best replacement for Eurodollar and that maybe it won't meet certain trading strategies. So now that we're sitting here, I don't know, 6 months after the real cutoff, is the marketplace different at all? Are you seeing certain strategies not being applied anymore? And is that still room for innovation for you? Or is SOFR and Eurodollar basically now the same thing, as it always was?
So I'm going to let Tim answer as well, Alex. But I will say the following, that the reason why people believe that SOFR might not be as good as your Eurodollar is because of pure uncertainty. When you know a certain way for so many decades of how you're going to price short-term interest rates, and all of a sudden, the governments say you have to change them, it's the uncertainty of the marketplace, for starters.
As far as it goes to the strategies, I think Tim already outlined the open interest in trade and SOFR. So you would have to say the answer to question number two, are people not doing certain strategies? Is no.
So question number three is are -- is there opportunity for people, I think was the last thing you had asked for the SOFR versus what was not in the LIBOR. And I'll turn that to Tim.
Yes. Thanks, Terry, and thanks, Alex, for the question. I think what's interesting is, when we see several months after the transition, we look at the SOFR complex at CME. Year-to-date through Q3, I believe we're already about 14% above the best year in Eurodollar previously. And we still have a whole quarter to go, which is exciting.
So certainly adopted, certainly being integrated. We're seeing similar strategies with respect to the various option strategies, the futures, the outrights, the spread. So we're really pleased with how the ecosystem is coming along.
But the one thing I would add is we also have new additional short-term interest rate products that can be spread against SOFR. When we look at the introductions of T-bills, and as Terry said in his opening comments with respect to us leading and taking really strong roots in the ESTR market overseas, these are all new things that are additive to the ecosystem that didn't exist when Eurodollars were around.
So very optimistic for the future, and further buttressed by our efforts on the CME term SOFR front with respect to licensing and the IP and the gravity that we're lending to that complex. These are all great things that continue to position not only SOFR, but the rest of our rates complex, given the interrelatedness and the spread strategies that exist, as we head into next year.
Our next question is a follow-up question from the line of Brian Bedell with Deutsche Bank.
It's on RPC. Just some of the drivers in the third quarter that you mentioned were member mix and product mix. I think that was mostly on the product mix side between asset classes. I was wondering if you could comment a little bit about were there any outliers within the asset classes that significantly impacted the RPC?
And then it looks like geography-wise, your non-U.S. was actually up a little bit sequentially. And I thought that was -- usually it's typically the higher RPC. So maybe just some comments on that.
And then also just on options versus futures, if you can remind us on the differentials there. I think, Derek, you mentioned the options volumes in energy in particular were up nicely in October.
Yes, Brian, 2 parts to your question. So I'm going to ask Lynne to comment on the RPC and then ask Derek to comment on the international business, which you're correct, does carry a higher RPC than the traditional -- some of the stuff here in the U.S. But go ahead, Lynne.
Yes. So if you look at the overall RPC of $0.707 versus the prior quarter of $0.724, so down $0.017. The drivers for that were really lower proportion coming from commodities products, so it was about 18% this quarter, down from about 19.5% last quarter. We did also see a slight increase in member mix and the contribution from micros overall.
In terms of the specific asset classes, I wouldn't call anything out as unusual per se. I would just point you to, if you look at the year-over-year basis, on very similar volume, we saw a 12% uplift on RPC. That's driven by a couple of things. You do have a lower proportion coming from micros. You have an increase in the commodities as we've seen that rebound in this year. And you are seeing the impact of that pricing change rolling through.
Thanks, Lynne. Derek, do you want to talk a little bit about the non-U.S. business as it relates to the RPC?
Yes. Thanks, Brian. We are seeing some continued really strong growth and building on the back of what was a record 2022 for non-U.S. business, we're building on that. Again, our Q3 international volume was up 7% this year, and that was led by some of the higher-RPC products. Our ag non-U.S. business is up 32%, energy up 30%, rates were up 6%, metals up 10%.
Also what you saw, and I think you might have mentioned this, our non-U.S. options continues to grow extremely strongly as well. So our non-U.S. options volumes up 31% while the overall options is up 21%. So a good, strong story within a good, strong story.
So we saw EMEA be a particular standout there relative to the volumes. And I think we're -- the efforts we put into place, boots on the ground, you heard us talk about the investment we're making in the majority of our sales force now being outside the U.S. is accelerating both our new clients acquisition opportunities as well as reinforcing the cross-selling into our existing customer base.
So our non-U.S. business continues to be a source of strength and new client growth for us. And I think we'll see that we're on track for another record year for that side of the business across asset classes, and we like our position going into '24.
So just to sum that up, Brian, because I think it's a really important question. Not a particular asset class where there's degradation in the RPC so much, it was more the mix of member versus non. And then we have some of these really outlier -- not outliers, but some higher-rate RPCs and some of the energies, as Lynne referenced. And it's a very sensitive tool, so that can move it a little bit, and that's what you saw.
That's great. And then just can you remind us on the RPC of options versus futures in general?
Yes.
Yes. So the total RPC for options this quarter were $0.658.
Our next question is from the line of Owen Lau with Oppenheimer.
I think CME recently launched the WTI Crude Oil Monday and Wednesday Weekly options. I'm just wondering how much incremental opportunity and demand for these kind of 0DTE products, not just in energy, but in the whole CME platform.
Thanks, Owen. Derek?
Yes. So on the weekly stuff, yes, we have had really great success across the entire franchise of launching additional points on the maturity curve. We've recently launched Mondays and Wednesdays in energy, particularly in WTI. We've actually set a number of records there. We had an all day record ADV of about 43,000 contracts on the first of September, and that was after the addition of the Mondays and Wednesdays. We set a single-day record on the same day of about 15,000 contracts.
When you look at that opportunity for us, we've talked about this before. Certainly, in a world with as much risk as we see on any given day, on any particular asset class, adding additional maturity points and a granular levels of risk management have proven to be successful. We sort of -- we plumbed that path with equities. We've incrementally rolled out asset classes. And I think over time, we found our customers have adopted those more broadly. Those are additive to the OI pool. Those have created more opportunities for spreading across maturities.
But I would also note that our record options growth is accelerating, not just on the front end of the curve but across the entire maturity curve. So we're seeing growth there where the short-dated pieces are additive to the growth, but it's actually being led by farther out across the curve. So we see those as additional tools and nice additive pieces of growth, but not the primary source of growth.
The next question is a last question from -- a follow-up from Craig Siegenthaler with Bank of America.
This is Eli from Craig's team. I was wondering if...
Can you speak up just a little bit, Eli? I think it was Eli, not Craig on the phone.
Yes. This is Eli from Craig's team. I was wondering if you could give us a sense of the potential impact of approval of the spot crypto ETFs on your crypto complex. What proportion of volumes did the futures-based ETF managers contribute to that complex today? And if we see like a migration from the future-based vehicles to spot, would that threaten the viability of that complex?
Yes. Good question, Eli. Thank you. Tim?
Thanks, Eli. Thanks, Terry. Certainly, a pressing question, given the recent moves that we've seen in Bitcoin. And I think one thing to note is that, before we dive into the nuances of the ETF, we've also seen tremendous volume in OI growth here in the third quarter for our crypto complex.
Just this week, we saw over 130,000 contracts trade, worth about $7.6 billion. That's our largest day in the crypto complex since the wake of the FTX collapse in a little over a year ago. So when we saw also a record OI in our Bitcoin futures over 20,000 contracts, which is equivalent to more than 100,000 Bitcoin. And this really speaks to the fact that we are an institutional-grade offering for the crypto community. So it is not surprising that we're the underlying for a lot of the futures-based ETFs, which has done phenomenally well in terms of serving the marketplace to date.
Certainly, there's a belief that some of the upwelling of price to almost $35,000, $36,000 we've seen this week is on the belief of spot-based ETF approvals. I'm not necessarily here to comment on whether that's going to happen. But what I can tell you is that we do see the introduction of additional structured products, whether it be spot or other underlying base in the crypto community, will be additive to our complex at CME on 2 fronts.
One, these markets are highly interrelated, where futures will not only be the underlying for some of these products, they will also be the hedge mechanism for market makers as well as market participants looking to hedge their digital or ETF-based holdings.
And the second thing to always keep in mind is we also have the CME CF Bitcoin reference rate, which is the underlying for a lot of these ETFs coming to market. So not only will be additive to our futures-based volume as we've seen in other asset classes such as equity, it's also to keep in mind as these products take root and grow in the market, there will be additional revenue-generation opportunities from the licensing front as a function of AUM and derived license fees here at CME as the IP owner of the underlying [indiscernible].
And there are no further questions. I'll turn it back over to management for closing remarks.
I want to thank you all very much. Excellent questions today. We appreciate it very much, and we wish you a good day, and everybody stay safe. Thank you.
Thank you, ladies and gentlemen. That does conclude today's call. We thank you for your participation and ask that you please disconnect your lines. Have a good day.